Ubs Asset Management Americas Inc Bridge Bio Pharma, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 609,588 shares of BBIO stock, worth $22.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
609,588
Previous 660,265
7.68%
Holding current value
$22.5 Million
Previous $16.8 Million
0.49%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$931 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$926 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$459 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$228 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.46B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...